Leit í EES-gagnagrunni
Commission Implementing Regulation (EU) …/... of XXX amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances dodemorph, fatty acids C8-C10 methyl esters, lauric acid, methyl octanoate, methyl decanoate, oleic acid and Trichoderma atroviride (formerly T. harzianum) strain IMI 206040
Commission Implementing Regulation (EU) …/... of XXX concerning the non-renewal of the approval of the active substance dimethomorph, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Commission Implementing Regulation (EU) …/... of XXX amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, dithianon, dodine, fluometuron, hexythiazox, isoxaben, lime sulphur, orange oil, prosulfuron, quinmerac, sintofen, sodium silver thiosulfate, tau fluvalinate, tebufenozide, tembotrione and zinc phosphide
Commission Implementing Regulation (EU) …/... of XXX concerning the non-renewal of the approval of the active substance mepanipyrim, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
Commission Delegated Regulation (EU) …/... amending Regulation (EU) 2019/1021 of the European Parliament and of the Council as regards hexabromocyclododecane
Commission Delegated Regulation (EU) …/... amending Regulation (EU) No 528/2012 of the European Parliament and of the Council as regards a further extension of the duration of the work programme for the systematic examination of all existing biocidal active substances
Commission Regulation (EU) …/… of XXX amending Regulation (EC) No 440/2008 as regards the test methods, to adapt them to technical progress
Commission Delegated Directive (EU) .../… amending Directive 2011/65/EU of the European Parliament and of the Council as regards an exemption for cadmium in downshifting quantum dots directly deposited on LED semiconductor chips
Commission Regulation (EU) …/… of XXX amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council as regards undecafluorohexanoic acid (PFHxA), its salts and PFHxA-related substances
D095068/01
Commission Implementing Decision (EU) 2024/888 of 22 March 2024 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) 2024/772 of 4 March 2024 granting a Union authorisation for the single biocidal product AEROCLEAN in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Delegated Regulation (EU) …/... amending Regulation (EU) No 528/2012 of the European Parliament and of the Council to include nitrogen generated from ambient air as an active substance in Annex I thereto
Commission Implementing Regulation (EU) …/... of XXX granting a Union authorisation for the biocidal product family ‘Kersia's Lactic acid based products’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094609/02
Commission Implementing Regulation (EU) 2024/836 of 12 March 2024 approving the basic substance magnesium hydroxide E528 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
D094047/03
Commission Implementing Regulation (EU) 2024/835 of 12 March 2024 renewing the approval of the active substance trinexapac, as trinexapac-ethyl, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
D094303/03
Commission Implementing Regulation (EU) 2024/839 of 8 March 2024 renewing the approval of the low-risk active substance urea in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
D094185/03
Commission Implementing Regulation (EU) 2024/821 of 8 March 2024 renewing the approval of the low-risk active substance hydrolysed proteins in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011
D094983/01
Commission Implementing Decision (EU) 2024/732 of 28 February 2024 postponing the expiry date of the approval of aluminium phosphide for use in biocidal products of product-types 14 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094022/02
Commission Implementing Decision (EU) 2024/731 of 28 February 2024 postponing the expiry date of the approval of indoxacarb for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) …/... of XXX granting a Union authorisation for the biocidal product family ‘Taski-Room Care-Suma Family based on Lactic Acid’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094984/01
Commission Implementing Decision (EU) 2024/787 of 28 February 2024 postponing the expiry date of the approval of magnesium phosphide for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094927/01
Commission Implementing Decision (EU) 2024/734 of 27 February 2024 postponing the expiry date of the approval of brodifacoum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone and flocoumafen for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094023/02
Commission Implementing Decision (EU) 2024/733 of 28 February 2024 postponing the expiry date of the approval of cholecalciferol for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094026/02
Commission Implementing Decision (EU) 2024/816 of 5 March 2024 addressing questions regarding the second comparative assessment of anticoagulant rodenticide biocidal products in accordance with Article 23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Regulation (EU) …/... of XXX granting a Union authorisation for the biocidal product family ‘STERI-PEROX’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council